Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clinton Yam

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Cancers|July 14, 2023
Predictive Roles of Baseline Stromal Tumor-Infiltrating Lymphocytes and Ki-67 in Pathologic Complete Response in an Early-Stage Triple-Negative Breast Cancer Prospective TrialNour Abuhadra, Ryan Sun, Clinton Yam, et al.
NPJ Breast Cancer|November 20, 2025
Early tumor volume reduction by breast DCE MRI predicts pathologic complete response to neoadjuvant therapy in triple negative breast cancerMary S Guirguis, Beatriz E Adrada, Clinton Yam, et al.
Cancers|March 28, 2025
Deep Learning Models Based on Pretreatment MRI and Clinicopathological Data to Predict Responses to Neoadjuvant Systemic Therapy in Triple-Negative Breast CancerZhan Xu, Zijian Zhou, Jong Bum Son, et al.
Cancers|October 14, 2023
Deep Learning for Fully Automatic Tumor Segmentation on Serially Acquired Dynamic Contrast-Enhanced MRI Images of Triple-Negative Breast CancerZhan Xu, David E Rauch, Rania M Mohamed, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 2, 2022
Quantitative Apparent Diffusion Coefficients From Peritumoral Regions as Early Predictors of Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast CancerBenjamin C Musall, Beatriz E Adrada, Rosalind P Candelaria, et al.
Cancers|February 25, 2023
Assessment of Response to Neoadjuvant Systemic Treatment in Triple-Negative Breast Cancer Using Functional Tumor Volumes from Longitudinal Dynamic Contrast-Enhanced MRIBikash Panthi, Beatriz E Adrada, Rosalind P Candelaria, et al.
Journal of Magnetic Resonance Imaging : JMRI|January 31, 2024
Diffusion Tensor Imaging for Characterizing Changes in Triple-Negative Breast Cancer During Neoadjuvant Systemic TherapyBenjamin C Musall, David E Rauch, Rania M M Mohamed, et al.
Therapeutic Advances in Medical Oncology|August 7, 2023
PTEN in triple-negative breast carcinoma: protein expression and genomic alteration in pretreatment and posttreatment specimensHui Chen, Qingqing Ding, Laila Khazai, et al.
Breast Cancer Research : BCR|May 7, 2026
The ARTEMIS trial identifies immune activation as a key predictor of neoadjuvant chemotherapy response in triple-negative breast cancerSahil Seth, Clinton Yam, Lei Huo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2021
Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast CancerClinton Yam, Er-Yen Yen, Jeffrey T Chang, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Cancers|July 14, 2023
Predictive Roles of Baseline Stromal Tumor-Infiltrating Lymphocytes and Ki-67 in Pathologic Complete Response in an Early-Stage Triple-Negative Breast Cancer Prospective TrialNour Abuhadra, Ryan Sun, Clinton Yam, et al.
NPJ Breast Cancer|November 20, 2025
Early tumor volume reduction by breast DCE MRI predicts pathologic complete response to neoadjuvant therapy in triple negative breast cancerMary S Guirguis, Beatriz E Adrada, Clinton Yam, et al.
Cancers|March 28, 2025
Deep Learning Models Based on Pretreatment MRI and Clinicopathological Data to Predict Responses to Neoadjuvant Systemic Therapy in Triple-Negative Breast CancerZhan Xu, Zijian Zhou, Jong Bum Son, et al.
Cancers|October 14, 2023
Deep Learning for Fully Automatic Tumor Segmentation on Serially Acquired Dynamic Contrast-Enhanced MRI Images of Triple-Negative Breast CancerZhan Xu, David E Rauch, Rania M Mohamed, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 2, 2022
Quantitative Apparent Diffusion Coefficients From Peritumoral Regions as Early Predictors of Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast CancerBenjamin C Musall, Beatriz E Adrada, Rosalind P Candelaria, et al.
Cancers|February 25, 2023
Assessment of Response to Neoadjuvant Systemic Treatment in Triple-Negative Breast Cancer Using Functional Tumor Volumes from Longitudinal Dynamic Contrast-Enhanced MRIBikash Panthi, Beatriz E Adrada, Rosalind P Candelaria, et al.
Journal of Magnetic Resonance Imaging : JMRI|January 31, 2024
Diffusion Tensor Imaging for Characterizing Changes in Triple-Negative Breast Cancer During Neoadjuvant Systemic TherapyBenjamin C Musall, David E Rauch, Rania M M Mohamed, et al.
Therapeutic Advances in Medical Oncology|August 7, 2023
PTEN in triple-negative breast carcinoma: protein expression and genomic alteration in pretreatment and posttreatment specimensHui Chen, Qingqing Ding, Laila Khazai, et al.
Breast Cancer Research : BCR|May 7, 2026
The ARTEMIS trial identifies immune activation as a key predictor of neoadjuvant chemotherapy response in triple-negative breast cancerSahil Seth, Clinton Yam, Lei Huo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2021
Immune Phenotype and Response to Neoadjuvant Therapy in Triple-Negative Breast CancerClinton Yam, Er-Yen Yen, Jeffrey T Chang, et al.
Pageof 7